Antioxidant potential of propylthiouracil in patients with psoriasis

Clinical Biochemistry

Volumn 35, Issue 3, 2002, Pages 241-246

  Utaş, Serap ^a,b   Köse, Kader ^b   Yazici, Cevad ^b   Akdaş, Ahmet ^a,b   Keleştimur, Fahrettin ^a  

^a ERCIYES UNIVERSITY   (Turkey)

^b Department of Biochemistry ^*

Author keywords

Glutathione peroxidase; Malondialdehyde; Psoriasis; Superoxide dismutase; Thyroid functions

Indexed keywords

ANTIOXIDANT; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; PROPYLTHIOURACIL; SUPEROXIDE DISMUTASE; TEFOR; THYROXINE; ANTITHYROID AGENT; OXIDIZING AGENT;

ADOLESCENT; ADULT; AGED; ANTIOXIDANT ACTIVITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; ENZYME BLOOD LEVEL; ERYTHROCYTE; FEMALE; HUMAN; HUMAN TISSUE; HYPOTHYROIDISM; IMMUNOMODULATION; LIPID PEROXIDATION; MALE; PRIORITY JOURNAL; PSORIASIS; SKIN BIOPSY; THYROID FUNCTION; TREATMENT OUTCOME; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; METABOLISM; MIDDLE AGED; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ADULT; AGED; ANTIOXIDANTS; ANTITHYROID AGENTS; FEMALE; GLUTATHIONE PEROXIDASE; HUMAN; MALE; MALONDIALDEHYDE; MIDDLE AGE; OXIDANTS; PROPYLTHIOURACIL; PSORIASIS; SUPEROXIDE DISMUTASE; THYROXINE; HUMANS; MIDDLE AGED;

EID: 0036017356     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9120(02)00294-1     Document Type: Article

References (34)

1. A survey of reactive oxygen species and their role in dermatology
2. Psoriasis: Current concepts and new approaches to therapy
3. A deficient function of the antioxidative system of the organism as an aetiopathogenic factor in psoriasis
4. Psoriasis
5. The effect of antithyroid drugs on B and T cell activity in vitro
6. Antioxidant activity of propylthiouracil
7. Propylthiouracil in psoriasis: Results of an open trial
8. A controlled trial of topi-cal propylthiouracil in the treatment of patients with psoriasis
9. Effect of propylthiouracil on adenosine deaminase activity and thyroid function in patients with psoriasis
10. Assessment of disease progress in psoriasis
11. Lipoperoxides in plasma as measured by liquid-chromatographic separation of malondialdehyde-thiobarbituric acid adduct
12. Evidence for membrane lipid peroxidation during the in vivo aging of human erythrocytes
13. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction
14. A simple method for clinical assay of superoxide dismuta-se
15. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase
16. Protein measurement with the folin phenol reagent
17. Effect of propylthiouracil and methimazole on serum levels of interleukin-2 receptors in patients with psoriasis
18. Serum ICAM-1 concentrations in patients with psoriasis treated with antithyroid thioureylenes
19. Serum IL-2 receptor levels in patients with psoriasis. Society Proceedings. British Society for Investigative Dermatology. Annual Meeting, Manchester, September 1988
20. Cyclosporin A suppresses ICAM-1 expression by papillary endothelium in healing psoriatic plaques
21. Effect of administered antithyroid thioureylenes on PCNA and P53 expression in psoriatic lesions
22. Inhibitory effects of antithyroid drugs on oxygen radical formation in human neutrophils
23. Methimazole and propylthiouracil inhibit the oxygen free radical-induced expression of a 72 Kilodalton Heat Shock Proten in Graves' retroocular fibroblasts
24. Increased lipid peroxidation in hyperthyroid patients: Suppression by propylthiouracil treatment
25. Effects of psoriatic sera on the generation of oxygen intermediates by normal polymorphonuclear leukocytes
26. The lipid peroxidation status of psoriasis patients
27. Antioxidants and lipid peroxidation status in the blood of patients with psoriasis
28. Lipoprotein peroxidation in adult psoriatic patients
29. Effect of percutaneous absobtion of fluocinolone acetonide on the activity of superoxide dismutase and total antioxidant status in patients with psoriasis
30. Superoxide dismutase and myeloperoxidase activity in polymorphonuclear leukocytes, and serum ceruloplasmin and copper levels, in psoriasis
31. Protective enzymes in human epidermal carcinomas and psoriasis
32. Superoxide dismutase in psoriasis, squamous cell carcinoma and basal cell epithelioma: An immunohistochemical study
33. Superoxide dismutase and catalase activity in psoriatic patients treated topically with ointment containing 2-chloroethyl-3-chloropropyl sulfide
34. Blood glutathione peroxida-se levels in skin disease: Effect of selenium and vitamin E treatment